Expression of DNA cytosine deaminase APOBEC3 proteins, a potential source for producing mutations, in gastric, colorectal and prostate cancers

Tumori

Volumn 100, Issue 4, 2014, Pages e112-e117

  Gwak, Min ^a   Choi, Youn Jin ^a   Yoo, Nam Jin ^a   Lee, Sug Hyung ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

APOBEC3B; Colorectal cancer; DNA cytosine deaminase; Expression; Gastric cancer; Prostate cancer

Indexed keywords

APOBEC3 PROTEIN; APOBEC3B PROTEIN; APOBEC3D PROTEIN; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3F; CYTOSINE DEAMINASE; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; APOBEC3 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGE; AGED; ARTICLE; BREAST; BREAST CANCER; CANCER CELL; COLON; COLORECTAL CANCER; CONTROLLED STUDY; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; PROSTATE; PROSTATE CANCER; PROTEIN EXPRESSION; STOMACH; STOMACH CANCER; TISSUE MICROARRAY; CHEMISTRY; COLORECTAL TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; MIDDLE AGED; MUTATION; PROSTATE TUMOR; STOMACH TUMOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; CYTOSINE DEAMINASE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; PROSTATIC NEOPLASMS; STOMACH NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84908152209     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1700/1636.17922     Document Type: Article

References (17)

1. Wedekind JE, Dance GS, Sowden MP, Smith HC: Messenger RNA editing in mammals: New members of the APOBEC family seeking roles in the family business. Trends Genet, 19: 207-216, 2003.
2. Navaratnam N, Sarwar R: An overview of cytidine deaminases. Int J Hematol, 83: 195-200, 2006.
3. Bass BL: RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem, 71: 817-846, 2002.
4. Harris RS, Petersen-Mahrt SK, Neuberger MS: RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol Cell, 10: 1247-1253, 2002.
5. Beale RC, Petersen-Mahrt SK, Watt IN, Harris RS, Rada C, Neuberger MS: Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: Correlation with mutation spectra in vivo. J Mol Biol, 337: 585-596, 2004.
6. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell, 100: 57-70, 2000.
7. Velculescu VE: Defining the blueprint of the cancer genome. Carcinogenesis, 29: 1087-1091, 2008.
8. Burns MB, Lackey L, Carpenter MA, Rathore A, Land AM, Leonard B, Refsland EW, Kotandeniya D, Tretyakova N, Nikas JB, Yee D, Temiz NA, Donohue DE, McDougle RM, Brown WL, Law EK, Harris RS: APOBEC3B is an enzymatic source of mutation in breast cancer. Nature, 494: 366-370, 2013.
9. Yoo NJ, Kim HR, Kim YR, An CH, Lee SH: Somatic mutations of the KEAP1 gene in common solid cancers. Histopathology, 60: 943-952, 2012.
10. Je EM, Kim MR, Min KO, Yoo NJ, Lee SH: Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors. Int J Cancer, 131: E1044-1047, 2012.
11. Nik-Zainal S, Alexandrov LB, Wedge DC, Van Loo P, Greenman CD, Raine K, Jones D, Hinton J, Marshall J, Stebbings LA, Menzies A, Martin S, Leung K, Chen L, Leroy C, Ramakrishna M, Rance R, Lau KW, Mudie LJ, Varela I, McBride DJ, Bignell GR, Cooke SL, Shlien A, Gamble J, Whitmore I, Maddison M, Tarpey PS, Davies HR, Papaemmanuil E, Stephens PJ, McLaren S, Butler AP, Teague JW, Jönsson G, Garber JE, Silver D, Miron P, Fatima A, Boyault S, Langerød A, Tutt A, Martens JW, Aparicio SA, Borg A, Salomon AV, Thomas G, Børresen-Dale AL, Richardson AL, Neuberger MS, Futreal PA, Campbell PJ, Stratton MR; Breast Cancer Working Group of the International Cancer Genome Consortium: Mutational processes molding the genomes of 21 breast cancers. Cell, 149: 979-993, 2012.
12. Stephens PJ, Tarpey PS, Davies H, Van Loo P, Greenman C, Wedge DC, Nik-Zainal S, Martin S, Varela I, Bignell GR, Yates LR, Papaemmanuil E, Beare D, Butler A, Cheverton A, Gamble J, Hinton J, Jia M, Jayakumar A, Jones D, Latimer C, Lau KW, McLaren S, McBride DJ, Menzies A, Mudie L, Raine K, Rad R, Chapman MS, Teague J, Easton D, Langerød A; Oslo Breast Cancer Consortium (OSBREAC), Lee MT, Shen CY, Tee BT, Huimin BW, Broeks A, Vargas AC, Turashvili G, Martens J, Fatima A, Miron P, Chin SF, Thomas G, Boyault S, Mariani O, Lakhani SR, van de Vijver M, van't Veer L, Foekens J, Desmedt C, Sotiriou C, Tutt A, Caldas C, Reis-Filho JS, Aparicio SA, Salomon AV, Børresen-Dale AL, Richardson AL, Campbell PJ, Futreal PA, Stratton MR: The landscape of cancer genes and mutational processes in breast cancer. Nature, 486: 400-404, 2012.
13. Cancer Genome Atlas Network: Comprehensive molecular portraits of human breast tumours. Nature, 490: 61-70, 2012.
14. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, Edkins S, O'Meara S, Vastrik I, Schmidt EE, Avis T, Barthorpe S, Bhamra G, Buck G, Choudhury B, Clements J, Cole J, Dicks E, Forbes S, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Jenkinson A, Jones D, Menzies A, Mironenko T, Perry J, Raine K, Richardson D, Shepherd R, Small A, Tofts C, Varian J, Webb T, West S, Widaa S, Yates A, Cahill DP, Louis DN, Goldstraw P, Nicholson AG, Brasseur F, Looijenga L, Weber BL, Chiew YE, DeFazio A, Greaves MF, Green AR, Campbell P, Birney E, Easton DF, Chenevix-Trench G, Tan MH, Khoo SK, Teh BT, Yuen ST, Leung SY, Wooster R, Futreal PA, Stratton MR: Patterns of somatic mutation in human cancer genomes. Nature, 446: 153-158, 2007.
15. Stenglein MD, Harris RS: APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. J Biol Chem, 281: 16837-16841, 2006.
16. Aguiar RS, Peterlin BM: APOBEC3 proteins and reverse transcription. Virus Res, 134: 74-85, 2008.
17. Lackey L, Demorest ZL, Land AM, Hultquist JF, Brown WL, Harris RS: APOBEC3B and AID have similar nuclear import mechanisms. J Mol Biol, 419: 301-314, 2012.